BOTOX Treatment in Adult Patients with Upper Limb Spasticity

Trial Profile

BOTOX Treatment in Adult Patients with Upper Limb Spasticity

Discontinued
Phase of Trial: Phase III

Latest Information Update: 28 Apr 2017

At a glance

  • Drugs Botulinum toxin A (Primary)
  • Indications Muscle spasticity
  • Focus Registrational; Therapeutic Use
  • Sponsors Allergan
  • Most Recent Events

    • 28 Apr 2017 Preliminary results of this trial assessing safety and efficacy presented at the 69th Annual Meeting of the American Academy of Neurology.
    • 20 Apr 2017 According to an Allergan media release, data from this study will be presented at the upcoming 69th American Academy of Neurology (AAN) annual meeting.
    • 02 Oct 2015 Planned end date changed from 1 Mar 2016 to 1 Dec 2015, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top